Inventor
CROUTHER NATHAN
US22 patents
⚠️ This page may combine multiple inventors who share the name “CROUTHER NATHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT DIABETES CARE INC
19 patentsUSD994695SAug 8, 2023
Display screen or portion thereof with graphical user interface for continuous glucose monitoring
ABBOTT DIABETES CARE INC25 citations94
US9351670B2May 31, 2016
Glycemic risk determination based on variability of glucose levels
ABBOTT DIABETES CARE INC21 citations92
US11331051B2May 17, 2022
Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
ABBOTT DIABETES CARE INC4 citations84
US11004566B2May 11, 2021
Systems, devices, and methods for episode detection and evaluation
ABBOTT DIABETES CARE INC7 citations84
US10130765B2Nov 20, 2018
Integrated insulin delivery system having safety features to prevent hypoglycemia
ABBOTT DIABETES CARE INC4 citations84
US10019554B2Jul 10, 2018
Glycemic risk determination based on variability of glucose
ABBOTT DIABETES CARE INC6 citations84
US11122043B2Sep 14, 2021
Systems, devices, and methods for authentication in an analyte monitoring environment
ABBOTT DIABETES CARE INC6 citations83
US9723082B2Aug 1, 2017
Management of multiple devices within an analyte monitoring environment
ABBOTT DIABETES CARE INC5 citations83
US9544313B2Jan 10, 2017
Systems, devices, and methods for authentication in an analyte monitoring environment
ABBOTT DIABETES CARE INC9 citations83
US10888272B2Jan 12, 2021
Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation
ABBOTT DIABETES CARE INC2 citations73
US10360368B2Jul 23, 2019
Application interface and display control in an analyte monitoring environment
ABBOTT DIABETES CARE INC5 citations73
US12424326B2Sep 23, 2025
Systems, devices, and methods for episode detection and evaluation
ABBOTT DIABETES CARE INC0 citations62
US12411930B2Sep 9, 2025
Application interface and display control in an analyte monitoring environment
ABBOTT DIABETES CARE INC0 citations62
US12178617B2Dec 31, 2024
Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
ABBOTT DIABETES CARE INC0 citations62
US12102454B2Oct 1, 2024
Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
ABBOTT DIABETES CARE INC0 citations62
US11185632B2Nov 30, 2021
Integrated insulin delivery system having safety features to prevent hypoglycemia
ABBOTT DIABETES CARE INC0 citations62
US10110603B2Oct 23, 2018
Systems, devices, and methods for authentication in an analyte monitoring environment
ABBOTT DIABETES CARE INC1 citations62
US10583251B2Mar 10, 2020
Integrated insulin delivery system having safety features to prevent hypoglycemia
ABBOTT DIABETES CARE INC0 citations52
US10383580B2Aug 20, 2019
Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
ABBOTT DIABETES CARE INC0 citations52